CanSinoBIO Reports Nine-Month Revenue Growth
CanSino Biologics reported revenue of approximately RMB 882 million for the nine months ended September 30, 2026.
Story updates
12:18:19 PM UTC
SquawkNews
CanSino Biologics Inc. reported 9M 2026 revenue of approx. RMB 882M, up 27.40% YoY, and net profit attributable to shareholders of approx. RMB 16.29M. Excluding non-recurring items, net loss narrowed 45.72% to approx. RMB 44.98M.Material DetailsContext by AI AnalystThis is mid-cycle confirmation of…
HONG KONG, Oct 27, 2026 - (ACN Newswire) - On October 27, 2026, CanSino Biologics Inc. (HKEX: 06185; SSE: 688185) released its third-quarter financial report for 2026. For the nine months ended September 30, 2026, the company reported revenue of approximately RMB 882 million, an increase of 27.40…